Is Viridian Therapeutics, Inc. (VRDN) a Buy, Sell, or Hold?
NASDAQ : VRDN
Viridian Therapeutics, Inc. — Analyst Ratings
$21.07 USD
$0.23 (1.1%)
- Volume
- 1.65M
- Average Volume
- 2.5M
- Market Capitalization
- $1.9B
- P/E Ratio
- -6.05
- Dividend Yield
- 0.00%
- Price Target
- $38.50
- Year High
- $34.29
- Year Low
- $13.18
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $15.15
Analyst Consensus Summary
Consensus Rating
Strong Sell
16 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-45.3%
vs Current Price
Price Target
$38.50
Average TargetPrice Target Range
Lowest Target
$26.00
-19.0% DOWNSIDE
Average Target
$38.50
Median Estimate
Highest Target
$45.00
-53.2% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 16
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 14 | 2 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Wedbush | Laura Chico | $43 | $18.6613 | 2026-06-29 12:25 PM | 130.4% |
| Truist Financial | Greg Renza | $35 | $18.445 | 2026-06-29 09:28 AM | 89.8% |
| Wells Fargo | Derek Archila | $31 | $18.58 | 2026-06-29 09:26 AM | 66.8% |